âMultiple Sclerosis (MS) was recognized as a distinct disease involving both the brain and spinal cord and associated with disseminated demyelinating plaques (âla sclÃ©rose en plaquesâ) and axonal damage more than 145 years ago by French neurologist Jean-Martin Charcot. Since that time, the world has witnessed many remarkable discoveries. Due to progress in physics and mathematics, MRI has become a powerful tool in neurology allowing us to follow the progression of demyelinating lesions in living patients. Based on progress made in the field of immunology, a number of immunomodulatory drugs have been discovered, tested in clinical trials and become standards of care for the treatment of patients with relapsing-remitting form of MSâ Balashov KE., Multiple Sclerosis: New Hypotheses Are Needed.
This progress and rapid growth in the field of multiple sclerosis has escalated the publications and number of journals related to multiple sclerosis. Journal of multiple sclerosis is international publication in the field of multiple sclerosis and neurology. This upcoming medical journal will be a different venture among multiple sclerosis article publishers.
Last date updated on July, 2021